Pashman Stein Walder Hayden P.C. Elevates Dillon J. McGuire to Partner
Pashman Stein Walder Hayden P.C. is pleased to announce that Dillon J. McGuire has been elevated to partner, effective January 1, 2024. McGuire is a member of the firm’s Criminal Defense, Governmental and Internal Investigations, and Cannabis & Hemp Law practices.
“Dillon is an exemplary lawyer who, through hard work, dedication, and excellent client service, has demonstrated his level of skill and professionalism to the practice of law,” said firm chair and managing partner Michael Stein. “Over the years, Dillon has built an outstanding reputation within the legal community through his leadership positions in the ACDL-NJ, which reflects our firm’s commitment to public service and public interest matters. We are thrilled to name Dillon as a partner at the firm.”
McGuire focuses on high-stakes federal investigations and prosecutions, as well as criminal matters in state and municipal courts. Clients turn to him for assistance in navigating the complexities of the criminal justice process, appreciating his dedication to keeping clients fully informed of every stage in the process and his passion in vigorously defending his clients’ constitutional rights. He has argued several cases before the Superior Court of New Jersey, Appellate Division, and the Supreme Court of New Jersey.
McGuire’s experience with criminal matters includes defending individuals and companies against allegations of securities fraud, insurance fraud, health care fraud, tax evasion, bank and mortgage fraud, money laundering, and both federal and state grand jury investigations. Additionally, he has represented clients accused of aggravated assault, murder, theft, sexual offenses, drug offenses, and state parole violations, as well as municipal court matters.
McGuire is also committed to advancing social justice and protecting the rights of the criminally accused through his pro bono work with the Justice Gary S. Stein Public Interest Center at Pashman Stein, preparing appellate briefs and appearing before the New Jersey Appellate Division and Supreme Court in numerous cases on behalf of the Association of Criminal Defense Lawyers-New Jersey (ACDL-NJ), as amicus curiae. He is a Trustee of the ACDL-NJ and is co-chair of its Young Lawyers Division. Of note, he has represented amici curiae organizations in New Jersey Supreme Court cases establishing important rights for medical marijuana patients. This work has led to McGuire being named recipient of the 2023 Distinguished New Lawyer Pro Bono Award by the New Jersey State Bar Association and being included in the 2022 "Insider 100: Cannabis Power List." He has also been selected for inclusion in the list of New Jersey Super Lawyers, Rising Star, 2021-2023, and inclusion in the list of Best Lawyers, Ones to Watch, Commercial Litigation, 2024.
Prior to joining the firm, McGuire earned his J.D., magna cum laude, from Rutgers Law School, and was inducted into the Order of the Coif. While attending Rutgers Law School, he was selected for a coveted fellowship with the Eagleton Institute of Politics and worked as a legislative aide in the non-partisan Office of Legislative Services. Following law school, he served as a judicial law clerk to the Honorable Margaret M. Foti, P.J.Cr., and then for the Honorable Robert J. Gilson, J.A.D., in the Superior Court of New Jersey, Appellate Division.
The New Jersey Rising Star list is issued by Thomson Reuters. A description of the selection methodology can be found at http://www.superlawyers.com/about/selection_process.html.
The Best Lawyers list is issued by Woodward/White, Inc. A description of the selection methodology can be found at https://www.bestlawyers.com/About/MethodologyBasic.aspx
No aspect of this advertisement has been approved by the Supreme Court of New Jersey.
Our firm is proud of the results it has achieved for clients, some of which are noted here. Of course, each legal matter is unique on many levels, and past successes are not a guarantee of results in any other pending or future matters.